首页 | 本学科首页   官方微博 | 高级检索  
     

腹腔免疫化疗治疗消化道肿瘤合并癌性腹水的疗效观察
引用本文:涂志全,张定昌. 腹腔免疫化疗治疗消化道肿瘤合并癌性腹水的疗效观察[J]. 肿瘤基础与临床, 2004, 17(4): 252-253
作者姓名:涂志全  张定昌
作者单位:上海市第八人民医院,上海,200235;上海市第八人民医院,上海,200235
摘    要:目的 探讨腹腔免疫化疗治疗晚期消化道肿瘤合并癌性腹水的近期疗效及相关机理。方法  2 8例消化道肿瘤合并癌性腹水患者采用顺铂 (DDP)加高聚金葡素 (HASL)或白介素 2 (IL -2 )进行腹腔灌注治疗 ,予B超测定患者治疗前、后腹水变化情况。结果腹腔免疫化疗治疗消化道肿瘤合并癌性腹水有效率 82 1%,其腹水消退率明显高于单纯腹腔化疗 ,而且毒性较低。结论 顺铂联合抗肿瘤生物调节剂腹腔内灌注对消化道肿瘤合并癌性腹水的治疗是一种安全、简便、有效的新方法

关 键 词:腹腔免疫化疗  消化道肿瘤  腹水
文章编号:1003-1464(2004)04-0252-02
修稿时间:2004-02-16

The Effects of Intraperitoneal Immunochemotherapy of Advanced Gastrointestinal Cancer with Ascites
Tu Zhiquan,Zhang Dingchang. The Effects of Intraperitoneal Immunochemotherapy of Advanced Gastrointestinal Cancer with Ascites[J]. Journal of Basic and Clinical Oncology, 2004, 17(4): 252-253
Authors:Tu Zhiquan  Zhang Dingchang
Abstract:Objective To observe the effects of intraperitoneal immunochemotherapy of advanced gastrointestinal cancer with ascites Methods 28 cases of advanced gastrointestinal cancer with ascites were treated with intraperitoneal injection of DDP and IL-2 or HASL The levels of ascites were determined by B ultrasonograph before and after the treatment Results The effective rate of intraperitoneal immunochemotherapy on advanced gastrointestinal cancer with ascites was 82 1% Conclusions The intraperitoneal immunochemotherapy was a simple, safe and effective method of treatment for advanced gastrointestinal cancer with ascites
Keywords:intraperitoneal immunochemotherapy  gastrointestinal cancer  ascites
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号